{"product_id":"olanib-150olaparib-inn-150-mg","title":"Olanib 150(Olaparib INN 150 mg)","description":"\u003cp class=\"PDq2pG_selectionAnchorContainer\"\u003e\u003cstrong\u003eOlanib 150\u003c\/strong\u003e contains \u003cstrong\u003eolaparib 150 mg\u003c\/strong\u003e and is manufactured by Everest Pharmaceuticals in Bangladesh. It is an \u003cstrong\u003eoral targeted cancer medicine\u003c\/strong\u003e belonging to the \u003cstrong\u003ePARP inhibitor\u003c\/strong\u003e class.\u003c\/p\u003e\n\u003cp class=\"PDq2pG_selectionAnchorContainer\"\u003eOlaparib works by blocking PARP proteins involved in DNA repair. This can make it difficult for certain cancer cells—especially those with \u003cstrong\u003eBRCA or other DNA-repair abnormalities\u003c\/strong\u003e—to survive. It is used for selected patients with \u003cstrong\u003eovarian, breast, pancreatic, and prostate cancers\u003c\/strong\u003e, depending on the cancer type and genetic\/biomarker results. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e Olanib 150 should be taken \u003cstrong\u003eonly under an oncologist's prescription\u003c\/strong\u003e. The 150 mg tablet is not necessarily the dose every patient should take; the usual tablet regimen for many indications is \u003cstrong\u003e300 mg twice daily\u003c\/strong\u003e, but the correct dose depends on the patient and cancer.\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":45022305976363,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/Olanib150_4d868bfe-e2d1-470c-878c-3f2e917cc2fa.jpg?v=1787512662","url":"https:\/\/xomeds.com\/es\/products\/olanib-150olaparib-inn-150-mg","provider":"XOMEDS","version":"1.0","type":"link"}